The metabolism of Bedaquiline can be decreased when combined with Ziprasidone. Triptorelin may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Fluvoxamine. Metoclopramide may increase the QTc-prolonging activities of Bedaquiline. Maprotiline may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Nefazodone. Indacaterol may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Quetiapine. The serum concentration of Bedaquiline can be increased when it is combined with Nelfinavir. Degarelix may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Stiripentol. The serum concentration of Bedaquiline can be decreased when it is combined with Rifampicin. Clomipramine may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Rucaparib. The metabolism of Bedaquiline can be decreased when combined with Olaparib. Bedaquiline may increase the QTc-prolonging activities of Zuclopenthixol. The serum concentration of Bedaquiline can be increased when it is combined with Netupitant. Apomorphine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with Siltuximab. Chloroquine may increase the QTc-prolonging activities of Bedaquiline. Nicardipine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Conivaptan can be increased when it is combined with Bedaquiline. Fingolimod may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Posaconazole. Bedaquiline may increase the QTc-prolonging activities of Escitalopram. The metabolism of Bedaquiline can be decreased when combined with Lovastatin. Telavancin may increase the QTc-prolonging activities of Bedaquiline. Crizotinib may increase the QTc-prolonging activities of Bedaquiline. Olanzapine may increase the QTc-prolonging activities of Bedaquiline. Propofol may increase the QTc-prolonging activities of Bedaquiline. Eribulin may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Telithromycin. Bedaquiline may increase the QTc-prolonging activities of Artemether. Bedaquiline may increase the QTc-prolonging activities of Disopyramide. Metronidazole may increase the QTc-prolonging activities of Bedaquiline. Salbutamol may increase the QTc-prolonging activities of Bedaquiline. Aripiprazole may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Sotalol. Sulfisoxazole may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Anagrelide. Rilpivirine may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Dihydroergotamine. Goserelin may increase the QTc-prolonging activities of Bedaquiline. Flecainide may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Diltiazem. Tizanidine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Ivacaftor. The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Bedaquiline. Sevoflurane may increase the QTc-prolonging activities of Bedaquiline. Mirtazapine may increase the QTc-prolonging activities of Bedaquiline. Promethazine may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Domperidone. Bedaquiline may increase the QTc-prolonging activities of Fluoxetine. Norfloxacin may increase the QTc-prolonging activities of Bedaquiline. Methotrimeprazine may increase the QTc-prolonging activities of Bedaquiline. Lithium may increase the QTc-prolonging activities of Bedaquiline. Treprostinil may increase the QTc-prolonging activities of Bedaquiline. Gemifloxacin may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Palbociclib. The serum concentration of Bedaquiline can be increased when it is combined with Simeprevir. Dolasetron may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Arsenic trioxide. Octreotide may increase the QTc-prolonging activities of Bedaquiline. Bortezomib may increase the QTc-prolonging activities of Bedaquiline. Propafenone may increase the QTc-prolonging activities of Bedaquiline. Pentamidine may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Quinidine. The metabolism of Bedaquiline can be decreased when combined with Fosamprenavir. Isradipine may increase the QTc-prolonging activities of Bedaquiline. Indapamide may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Idelalisib. Bedaquiline may increase the QTc-prolonging activities of Flupentixol. Bedaquiline may increase the QTc-prolonging activities of Toremifene. The serum concentration of Bedaquiline can be decreased when it is combined with Mitotane. Gadobenic acid may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Itraconazole. Azithromycin may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with St. John's Wort. Mirabegron may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Boceprevir. Bedaquiline may increase the QTc-prolonging activities of Citalopram. The serum concentration of Bedaquiline can be decreased when it is combined with Enzalutamide. The serum concentration of Bedaquiline can be decreased when it is combined with Phenobarbital. Desflurane may increase the QTc-prolonging activities of Bedaquiline. Amitriptyline may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with Carbamazepine. Bedaquiline may increase the QTc-prolonging activities of Thioridazine. The serum concentration of Bedaquiline can be increased when it is combined with Voriconazole. Amantadine may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Lenvatinib. The serum concentration of Bedaquiline can be increased when it is combined with Aprepitant. Venlafaxine may increase the QTc-prolonging activities of Bedaquiline. Ciprofloxacin may increase the QTc-prolonging activities of Bedaquiline. Ethanol may increase the hepatotoxic activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Osimertinib. The serum concentration of Bedaquiline can be decreased when it is combined with Tocilizumab. Droperidol may increase the QTc-prolonging activities of Bedaquiline. Imipramine may increase the QTc-prolonging activities of Bedaquiline. Vilanterol may increase the QTc-prolonging activities of Bedaquiline. Amoxapine may increase the QTc-prolonging activities of Bedaquiline. Methadone may increase the QTc-prolonging activities of Bedaquiline. Trimipramine may increase the QTc-prolonging activities of Bedaquiline. Vardenafil may increase the QTc-prolonging activities of Bedaquiline. Ivabradine may increase the QTc-prolonging activities of Bedaquiline. Moexipril may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Atazanavir. Famotidine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Clarithromycin. Granisetron may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with Vemurafenib. The serum concentration of Bedaquiline can be increased when it is combined with Telaprevir. Nortriptyline may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with Pentobarbital. Bedaquiline may increase the QTc-prolonging activities of Vandetanib. Thiothixene may increase the QTc-prolonging activities of Bedaquiline. Fluconazole may increase the QTc-prolonging activities of Bedaquiline. Ritonavir may increase the QTc-prolonging activities of Bedaquiline. Promazine may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be decreased when it is combined with Lumacaftor. Bedaquiline may increase the QTc-prolonging activities of Pimozide. Ezogabine may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Doxycycline. Paroxetine may increase the QTc-prolonging activities of Bedaquiline. Bedaquiline may increase the QTc-prolonging activities of Iloperidone. Solifenacin may increase the QTc-prolonging activities of Bedaquiline. The metabolism of Bedaquiline can be decreased when combined with Clotrimazole. Mefloquine may increase the QTc-prolonging activities of Bedaquiline. Pasireotide may increase the QTc-prolonging activities of Bedaquiline. The serum concentration of Bedaquiline can be increased when it is combined with Ceritinib. The serum concentration of Bedaquiline can be increased when it is combined with Fosaprepitant.